A brief overview of the key points discussed during a company’s quarterly earnings call, including financial performance, guidance, and management’s commentary on future outlook.
ContextVision Earnings
Estimates
Actual
Y-on-Y Change
Revenue
EPS
Transcripts
Events
About ContextVision AB (publ)
C
C
ContextVision AB (publ)
CONTX
ContextVision AB (publ), a software company, engages in the provision of image analysis and imaging for medical systems in Asia, Europe, and America. It offers image quality solutions for ultrasound; and its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardiology, women’s health, veterinary medicine, and point of-care applications. The company also provides Altumira platform which features scatter correction and improves radiography by enabling radiation dose reduction while enhancing image quality, such as Altumira for static applications; and Altumira Plus for dynamic applications. In addition, it offers image quality solutions for MRI including - GOPView MRI2Plus for the requirements of each application, sequence type, and protocol; implementation projects, software updates, and upgrades and product support services. The company has a strategic clinical development partnership with the University of Washington School of Medicine for collecting medical imaging data to identify a multiparametric biomarker for the screening and staging of the liver disease MASLD; and research partnership with AMRA Medical to develop AI-powered, organ-specific imaging solutions that enable MASLD screening and physiological quantification. ContextVision AB (publ) was founded in 1983 and is headquartered in Stockholm, Sweden.
ContextVision AB (publ), a software company, engages in the provision of image analysis and imaging for medical systems in Asia, Europe, and America. It offers image quality solutions for ultrasound; and its Rivent platform comprising Rivent, a 2D image enhancement; R...
ContextVision AB (publ), a software company, engages in the provision of image analysis and imaging for medical systems in Asia, Europe, and America. It offers image quality solutions for ultrasound; and its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardiology, women’s health, veterinary medicine, and point of-care applications. The company also provides Altumira platform which features scatter correction and improves radiography by enabling radiation dose reduction while enhancing image quality, such as Altumira for static applications; and Altumira Plus for dynamic applications. In addition, it offers image quality solutions for MRI including - GOPView MRI2Plus for the requirements of each application, sequence type, and protocol; implementation projects, software updates, and upgrades and product support services. The company has a strategic clinical development partnership with the University of Washington School of Medicine for collecting medical imaging data to identify a multiparametric biomarker for the screening and staging of the liver disease MASLD; and research partnership with AMRA Medical to develop AI-powered, organ-specific imaging solutions that enable MASLD screening and physiological quantification. ContextVision AB (publ) was founded in 1983 and is headquartered in Stockholm, Sweden.
Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach. Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
